VALLERINI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 5.103
EU - Europa 2.209
AS - Asia 631
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 8
AF - Africa 2
Totale 7.965
Nazione #
US - Stati Uniti d'America 5.086
GB - Regno Unito 847
SE - Svezia 393
IT - Italia 331
CN - Cina 222
DE - Germania 177
HK - Hong Kong 133
UA - Ucraina 117
FI - Finlandia 97
SG - Singapore 93
TR - Turchia 91
FR - Francia 72
BG - Bulgaria 48
IN - India 42
CZ - Repubblica Ceca 28
BE - Belgio 27
IE - Irlanda 12
VN - Vietnam 12
ID - Indonesia 10
RU - Federazione Russa 10
CA - Canada 9
EU - Europa 9
MY - Malesia 9
BZ - Belize 8
LT - Lituania 8
IR - Iran 7
ES - Italia 6
NL - Olanda 5
PL - Polonia 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
AT - Austria 3
DK - Danimarca 3
GR - Grecia 3
JP - Giappone 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
CL - Cile 2
CO - Colombia 2
KR - Corea 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BR - Brasile 1
EC - Ecuador 1
EE - Estonia 1
GN - Guinea 1
IQ - Iraq 1
KH - Cambogia 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
PE - Perù 1
SY - Repubblica araba siriana 1
Totale 7.965
Città #
Fairfield 801
Southend 686
Woodbridge 486
Ashburn 460
Chandler 432
Houston 359
Ann Arbor 344
Seattle 283
Nyköping 249
Wilmington 233
Cambridge 224
Jacksonville 216
Dearborn 211
Hong Kong 130
Modena 112
New York 85
Beijing 64
Fremont 63
Helsinki 56
San Diego 53
Sofia 47
Princeton 46
Bremen 45
Eugene 44
Izmir 43
Singapore 40
Des Moines 32
Boardman 26
Brussels 25
London 22
Redwood City 22
Milan 18
Shanghai 16
San Jose 14
Las Vegas 12
Dublin 11
Dong Ket 10
Hefei 10
Jakarta 10
Kunming 10
Albuquerque 9
Bologna 9
Brno 9
Chicago 9
Dallas 9
Belize City 8
Kilburn 8
Washington 8
Munich 7
Paris 7
Toronto 7
Bangalore 6
Chiswick 6
Guangzhou 6
Leawood 6
Nanjing 6
Norwalk 6
Rome 6
San Francisco 6
Bengaluru 5
Istanbul 5
Jinan 5
Prescot 5
Tulare 5
Wuhan 5
Kosice 4
Perugia 4
Rimini 4
Romainville 4
San Giuliano Milanese 4
Asti 3
Changsha 3
Chengdu 3
Columbus 3
Dongguan 3
Florence 3
Grafing 3
Hanover 3
Hounslow 3
Marienheide 3
Nanchang 3
Sacramento 3
Saint Louis 3
San Mateo 3
Segrate 3
Simi Valley 3
Sissa 3
Szczecin 3
Taipei 3
Vienna 3
Amsterdam 2
Andover 2
Atlanta 2
Boca 2
Boretto 2
Cachan 2
Campodarsego 2
Castelnuovo Rangone 2
Chongqing 2
Cormeilles-en-Parisis 2
Totale 6.318
Nome #
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 276
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 256
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 238
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 234
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 227
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 222
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 219
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 216
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 212
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 206
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 202
Mucorales-specific T cells in patients with hematologic malignancies 199
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 197
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 196
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 196
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 192
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 191
B cells and herpesviruses: a model of lymphoproliferation 190
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 189
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 189
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 188
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 186
Diagnosis of aspergillosis: Role of proteomics 184
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 179
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 177
Parvoviruses in blood donors and transplant patients, Italy 175
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 171
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 171
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 165
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 164
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 163
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 160
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 154
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 153
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 149
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 148
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 143
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 140
KSHV/HHV-8 infection of tubular epithelial cells in transplantation kidney 139
Fatal hemophagocytic syndrome related to active human herpesvirus-8/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies 136
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 132
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 131
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 125
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 115
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 114
Totale 8.109
Categoria #
all - tutte 28.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.850 124 65 69 123 208 256 368 245 175 60 80 77
2020/20211.396 99 77 90 180 177 94 78 177 65 184 94 81
2021/20221.124 44 138 143 61 27 41 61 57 96 99 225 132
2022/20231.284 191 180 80 129 197 151 47 108 100 9 51 41
2023/2024778 19 26 63 60 156 100 79 139 14 10 53 59
2024/202565 65 0 0 0 0 0 0 0 0 0 0 0
Totale 8.109